Author:
Abraham Mary B.,Shetty Vinutha B.,Price Glynis,Smith Nicholas,Bock Martin de,Siafarikas Aris,Resnick Steven,Whan Elizabeth,Ellard Sian,Flanagan Sarah E.,Davis Elizabeth A.,Jones Timothy W.,Hussain Khalid,Choong Catherine S.
Abstract
AbstractHyperinsulinaemic hypoglycaemia (HH) is characterised by inappropriate insulin secretion and is the most common cause for persistent neonatal hypoglycaemia. The only treatment available for medically unresponsive hypoglycaemia is a near-total pancreatectomy. A neonate with severe HH, due to a homozygous
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Pediatrics, Perinatology, and Child Health
Reference42 articles.
1. Sang Successful treatment of congenital hyperinsulinism with long - acting release octreotide;Le Quan;Eur J Endocrinol,2012
2. General recommendations on immunization Recommendations of the Advisory Committee on Immunization Practices;ACIP;Rep,2011
3. Long - term follow up of children with congenital hyperinsulinism on octreotide therapy;Demirbilek;J Clin Endocrinol Metab,2014
4. mTOR inhibitors in pediatric kidney transplantation;Pape;Pediatr Nephrol,2014
5. Persistent hyperinsulinaemic hypoglycaemia of infancy a heterogeneous syndrome unrelated to nesidioblastosis Neonatal;Rahier;Arch Dis Child Fetal,2000
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献